These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 30455200)
1. Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis. McHugh RE; O'Boyle N; Connolly JPR; Hoskisson PA; Roe AJ Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30455200 [TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis. McHugh RE; Munnoch JT; Braes RE; McKean IJW; Giard J; Taladriz-Sender A; Peschke F; Burley GA; Roe AJ; Hoskisson PA Appl Environ Microbiol; 2022 Aug; 88(15):e0069222. PubMed ID: 35867559 [TBL] [Abstract][Full Text] [Related]
3. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium. Kimura K; Iwatsuki M; Nagai T; Matsumoto A; Takahashi Y; Shiomi K; Omura S; Abe A J Antibiot (Tokyo); 2011 Feb; 64(2):197-203. PubMed ID: 21139624 [TBL] [Abstract][Full Text] [Related]
4. Insights into the structure-activity relationship of a type III secretion system inhibitor, aurodox. Kimishima A; Hagimoto D; Honsho M; Watanabe Y; Iwatsuki M; Tsutsumi H; Inahashi Y; Naher K; Sakai K; Kuwae A; Abe A; Asami Y Bioorg Med Chem Lett; 2022 Aug; 69():128779. PubMed ID: 35545199 [TBL] [Abstract][Full Text] [Related]
5. Induction of resistance to aurodox by aurodox in the antibiotic-producing culture, Streptomyces goldiniensis. Liu CM; Hermann TE; Miller PA J Antibiot (Tokyo); 1979 Oct; 32(10):1025-32. PubMed ID: 118955 [TBL] [Abstract][Full Text] [Related]
6. Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli. Chinali G J Antibiot (Tokyo); 1981 Aug; 34(8):1039-45. PubMed ID: 6119303 [TBL] [Abstract][Full Text] [Related]
7. Feedback inhibition of the synthesis of an antibiotic: aurodox (X-5108). Liu C; Hermann T; Miller PA J Antibiot (Tokyo); 1977 Mar; 30(3):244-51. PubMed ID: 405357 [TBL] [Abstract][Full Text] [Related]
8. Increased production of the antibiotic aurodox (X-5108) by aurodox-resistant mutants. Unowsky J; Hoppe DC J Antibiot (Tokyo); 1978 Jul; 31(7):662-6. PubMed ID: 357362 [TBL] [Abstract][Full Text] [Related]
9. PurA is the main target of aurodox, a type III secretion system inhibitor. Watanabe Y; Haneda T; Kimishima A; Kuwae A; Suga T; Suzuki T; Iwabuchi Y; Honsho M; Honma S; Iwatsuki M; Matsui H; Hanaki H; Kanoh N; Abe A; Asami Y; Ōmura S Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322363121. PubMed ID: 38640341 [TBL] [Abstract][Full Text] [Related]
10. Bioconversion capacity of Streptomyces sp GE44282, a producer of the antibiotics heneicomycin and aurodox. Marinelli F; Stella S; Montanini N; Le Monnier F; Cavaletti L; Selva E J Ind Microbiol; 1995 Jul; 15(1):49-54. PubMed ID: 7662297 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a high-content screening assay for inhibitors of enteropathogenic E. coli adhesion. Pylkkö T; Ilina P; Tammela P J Microbiol Methods; 2021 May; 184():106201. PubMed ID: 33713725 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of Escherichia coli elongation factor Tu-dependent GTP hydrolysis by aminoacyl oligonucleotides in the presence of aurodox. Bhuta P; Chládek S FEBS Lett; 1980 Dec; 122(1):113-6. PubMed ID: 6783438 [No Abstract] [Full Text] [Related]
13. Genome sequence of the aurodox-producing bacterium McHugh RE; Munnoch JT; Roe AJ; Hoskisson PA Access Microbiol; 2022 Aug; 4(5):acmi000358. PubMed ID: 36003359 [TBL] [Abstract][Full Text] [Related]
14. Novel compounds targeting the enterohemorrhagic Escherichia coli type three secretion system reveal insights into mechanisms of secretion inhibition. Zambelloni R; Connolly JPR; Huerta Uribe A; Burgess K; Marquez R; Roe AJ Mol Microbiol; 2017 Aug; 105(4):606-619. PubMed ID: 28557017 [TBL] [Abstract][Full Text] [Related]
15. Conformation and reactivity changes induced by N-methylkirromycin (aurodox) in elongation factor Tu. Balestrieri C; Giovane A; Quagliuolo L; Servillo L; Chinali G Biochemistry; 1989 Aug; 28(17):7097-101. PubMed ID: 2510820 [TBL] [Abstract][Full Text] [Related]
16. The structure of heneicomycin. Dewey RS; Hensens OD; Douglas AW; Albers-Schönberg G J Antibiot (Tokyo); 1991 Aug; 44(8):838-43. PubMed ID: 1917698 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic SB22484: a novel complex of the aurodox group. I. Taxonomy of the producing organism, isolation of the antibiotics and chemical and biological characterization. Selva E; Beretta G; Pallanza R; Goldstein BP; Berti M; Edwards DM; Denaro M J Antibiot (Tokyo); 1990 Nov; 43(11):1349-58. PubMed ID: 2272911 [TBL] [Abstract][Full Text] [Related]
18. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity. El Qaidi S; Wu M; Zhu C; Hardwidge PR Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307 [TBL] [Abstract][Full Text] [Related]
19. Effects of nucleotide- and aurodox-induced changes in elongation factor Tu conformation upon its interactions with aminoacyl transfer RNA. A fluorescence study. Dell VA; Miller DL; Johnson AE Biochemistry; 1990 Feb; 29(7):1757-63. PubMed ID: 2110000 [TBL] [Abstract][Full Text] [Related]
20. The Ruler Protein EscP of the Enteropathogenic Escherichia coli Type III Secretion System Is Involved in Calcium Sensing and Secretion Hierarchy Regulation by Interacting with the Gatekeeper Protein SepL. Shaulov L; Gershberg J; Deng W; Finlay BB; Sal-Man N mBio; 2017 Jan; 8(1):. PubMed ID: 28049143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]